A comparison of antenatally and intraoperatively diagnosed cases of placenta accreta spectrum (PAS)
To assess the effect of antenatal diagnosis of Placenta Accreta Spectrum (PAS) on fetomaternal outcomes. This was a retrospective cohort study conducted from January 2017 to December 2018. Women whose PAS was diagnosed antenatally were included as (GROUP A) and those where diagnosis was suspected during operation and confirmed on histopathology were included as PAS diagnosed peroperatively (GROUP B). Outcome in terms of uterine conservation, maternal death, admission of mother to ICU and perinatal death and NICU admission were recorded. During the study period, PAS was confirmed in 96 cases and were included. Out of these, 34 (35.4%) cases were antenatally diagnosed (group A) while 62 (64.6%) were diagnosed intraoperatively (Group B). Group A had lower median number of units of blood transfused as compared to group B (4 vs. 6, p˂0.001).Uterus was conserved in more cases (67.6% vs. 43.5%, p=0.024) of Group A and admission to ICU took place in (26.5% vs. 59.7%, p =0.002) more cases of GROUP B. Maternal death (p=0.038) and perinatal death (p=0.008) were also significantly higher in cases diagnosed intraoperatively (p=0.008). More neonates (85.7% vs. 24%, p=0.033) were admitted to ICU for cases diagnosed intraoperatively. Survival analysis showed a statistically significant difference in uterine conservation rate with antenatal diagnosis between the two groups (log rank, p value=0.04). PAS diagnosed antenatally has better fetomaternal outcomes than intraoperative detection of PAS. Diagnosing PAS antenatally is a key factor that influences management and results in better outcome.